Alpha-Galactosylceramide

Alpha-Galactosylceramide (α-GalCer) is a synthetic glycolipid that has been identified as a potent stimulator of natural killer T cells (NKT cells). It was first isolated from a marine sponge, but is now synthesized in laboratories for research and potential therapeutic use.

Structure

Alpha-Galactosylceramide is composed of a ceramide lipid moiety and a galactose sugar moiety. The ceramide portion contains a long-chain base and a fatty acid, while the galactose is attached to the ceramide via a glycosidic bond.

Biological Activity

Alpha-Galactosylceramide has been found to have potent immunostimulatory effects. It is recognized by the invariant T cell receptor (TCR) on NKT cells, leading to their activation. This results in the production of large amounts of cytokines, which can have various effects on the immune response.

Potential Therapeutic Use

Due to its ability to stimulate the immune system, alpha-Galactosylceramide has been investigated for potential use in cancer immunotherapy. It has been shown to enhance the anti-tumor response in several preclinical models. However, further research is needed to determine its safety and efficacy in humans.

See Also

• Glycolipid
• Natural killer T cell
• Cancer immunotherapy

References

‎ ‎

---

Translate: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, தமிழ், తెలుగు, Urdu, ಕನ್ನಡ, Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, বাংলা
European español, Deutsch, français, Greek, português do Brasil, polski, română, русский, Nederlands, norsk, svenska, suomi, Italian
Middle Eastern & African عربى, Turkish, Persian, Hebrew, Afrikaans, isiZulu, Kiswahili,
Other Bulgarian, Hungarian, Czech, Swedish, മലയാളം, मराठी, ਪੰਜਾਬੀ, ગુજરાતી, Portuguese, Ukrainian